Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact Contact Barchart
Market:
Vivos Therapeutics Inc (VVOS)
Vivos Therapeutics Inc (VVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Alerts
Watch
Help
Go To:
Marinus Pharmaceuticals (MRNS) Reports Q1 Loss, Tops Revenue Estimates Zacks - Thu May 11, 7:35AM CDT

Marinus Pharmaceuticals (MRNS) delivered earnings and revenue surprises of 12.99% and 94.86%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?...

MRNS : 8.00 (+2.11%)
VVOS : 0.1901 (-0.37%)
Exscientia PLC Sponsored ADR (EXAI) Reports Q3 Loss, Lags Revenue Estimates Zacks - Tue Nov 15, 2022

Exscientia PLC Sponsored ADR (EXAI) delivered earnings and revenue surprises of -72.73% and 47.93%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for...

EXAI : 4.71 (+0.64%)
VVOS : 0.1901 (-0.37%)
Impel Pharmaceuticals Inc. (IMPL) Reports Q3 Loss, Lags Revenue Estimates Zacks - Mon Nov 14, 2022

Impel Pharmaceuticals Inc. (IMPL) delivered earnings and revenue surprises of -50.57% and 40.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

IMPL : 0.5800 (+7.45%)
VVOS : 0.1901 (-0.37%)
Chinook Therapeutics (KDNY) Reports Q3 Loss, Tops Revenue Estimates Zacks - Thu Nov 10, 2022

Chinook (KDNY) delivered earnings and revenue surprises of -33.87% and 614.57%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

KDNY : 40.39 (+0.22%)
VVOS : 0.1901 (-0.37%)
Heron Therapeutics (HRTX) Reports Q3 Loss, Tops Revenue Estimates Zacks - Tue Nov 8, 2022

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of 2.56% and 1.27%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

HRTX : 0.9909 (-0.91%)
VVOS : 0.1901 (-0.37%)
Revolution Medicines, Inc. (RVMD) Reports Q2 Loss, Tops Revenue Estimates Zacks - Tue Aug 9, 2022

Revolution Medicines, Inc. (RVMD) delivered earnings and revenue surprises of 5.75% and 4.18%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

RVMD : 28.90 (-0.14%)
VVOS : 0.1901 (-0.37%)
Gain Therapeutics, Inc. (GANX) Reports Q2 Loss, Tops Revenue Estimates Zacks - Mon Aug 8, 2022

Gain Therapeutics, Inc. (GANX) delivered earnings and revenue surprises of -22.86% and 46.15%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

GANX : 3.21 (+0.31%)
VVOS : 0.1901 (-0.37%)
Corcept Therapeutics (CORT) Q2 Earnings Lag Estimates Zacks - Wed Aug 3, 2022

Corcept (CORT) delivered earnings and revenue surprises of -4% and 1.85%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

CORT : 32.37 (-0.31%)
VVOS : 0.1901 (-0.37%)
Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for Its Entire Line of Oral Appliances Business Wire - Thu Jul 14, 2022

Vivos Therapeutics, Inc . (NASDAQ: VVOS) is pleased to announce that it has received multiple Class I clearances by the Therapeutic Goods Administration for multiple indications to include the treatment...

VVOS : 0.1901 (-0.37%)
Vivos Therapeutics’ SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep Apnea Globe Newswire - Tue Jun 14, 2022

Study Recently Presented at the SLEEP 2022 Annual Meeting...

VVOS : 0.1901 (-0.37%)

Barchart Exclusives

Don't Miss This Top-Rated Oil Stock Under $10 Barchart - Wed Sep 27, 4:11PM CDT
This Canadian energy stock has a smart hedging strategy to manage commodity volatility - and could be looking at a serious gusher in free cash flow next year if oil prices stay elevated. Here's what you need to know about this low-priced oil stock. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot